EWTX CMO sells $685k worth of Edgewise Therapeutics shares

The Chief Medical Officer (CMO) of Edgewise Therapeutics (EWTX) sold $685,000 worth of the company's stock. This transaction highlights insider trading activity within EWTX, which could be interpreted as a response to the company's current performance in the market. The sale may affect investor confidence and market perception of Edgewise Therapeutics. Insider stock sales can indicate potential concerns or changes in corporate strategy that investors should consider.